inlineVision Competitors

Founded in 2014, SenseTime is a leading artificial intelligence (AI) software company, committed to its mission of "creating a better AI-empowered future through original innovation". The Company continues to lead cutting-edge AI research while accelerating the large-scale commercialisation of AI technologies. Leveraging deep academic expertise and strong in-house innovation capabilities, SenseTime continues to enhance its industry-leading multimodal, multi-task general AI capabilities, while fostering a vibrant developer ecosystem through structured open-source initiatives. SenseTime's business spans Generative AI, Vision AI, and emerging innovation-driven segments. Underpinned by SenseCore, its next-generation AI infrastructure, the Company integrates computing power, algorithms, and platforms to enable scalable AI deployment. Building on this foundation, SenseTime has developed the SenseNova foundation model series, delivering cost-efficient capabilities across a wide range of general AI tasks. SenseTime continues to lead the global Vision AI market, ranking No.1 worldwide by market share. Its SenseFoundry platform integrates years of accumulated computer vision expertise with advanced multimodal foundation models, providing stable and efficient Vision AI solutions to industries worldwide. SenseTime is listed on The Stock Exchange of Hong Kong, with operations spanning more than a dozen countries and regions.

The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world's first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.

Acutus Medical is a dynamic arrhythmia care company focused on developing distinct, innovative technologies that provide physicians and patients with improved results. AcQMap, AcQRef and AcQGuide devices are CE Marked and FDA cleared. Please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.